BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16235841)

  • 21. Subcategorization of resectable non-small cell lung cancer involving neighboring structures.
    Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T
    Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
    Miyoshi K; Moriyama S; Kunitomo T; Nawa S
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung cancer with chest wall involvement: predictive factors of long-term survival after surgical resection.
    Voltolini L; Rapicetta C; Luzzi L; Ghiribelli C; Ligabue T; Paladini P; Gotti G
    Lung Cancer; 2006 Jun; 52(3):359-64. PubMed ID: 16644062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
    Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcategorization of lung cancer based on tumor size and degree of visceral pleural invasion.
    Sakakura N; Mori S; Okuda K; Fukui T; Hatooka S; Shinoda M; Matsuo K; Yatabe Y; Yokoi K; Mitsudomi T
    Ann Thorac Surg; 2008 Oct; 86(4):1084-90. PubMed ID: 18805136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vertebral en bloc resection for lung cancer: twelve years' experience].
    Chadeyras JB; Mazel C; Grunenwald D
    Ann Chir; 2006 Dec; 131(10):616-22. PubMed ID: 16859631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience.
    Takeda S; Maeda H; Koma M; Matsubara Y; Sawabata N; Inoue M; Tokunaga T; Ohta M
    Eur J Cardiothorac Surg; 2006 Mar; 29(3):276-80. PubMed ID: 16434204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer.
    Schuchert MJ; Schumacher L; Kilic A; Close J; Landreneau JR; Pennathur A; Awais O; Yousem SA; Wilson DO; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2011 Apr; 91(4):1059-65; discussion 1065. PubMed ID: 21440123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.
    Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
    Ann Thorac Surg; 2009 Aug; 88(2):372-8. PubMed ID: 19632375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Perioperative targeting brachytherapy for lung cancer invading the chest wall].
    Takizawa M; Oda M; Ohta Y; Kawakami K; Tsunezuka Y; Matsumoto I; Tamura M; Yachi T; Watanabe G; Takanaka T; Nishijima H; Matsui O
    Kyobu Geka; 2004 Dec; 57(13):1198-201. PubMed ID: 15609656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is primary resection of stage IIIA lung cancer futile?
    Grannis FW
    Ann Thorac Surg; 2008 Jul; 86(1):353-4; author reply 354. PubMed ID: 18573468
    [No Abstract]   [Full Text] [Related]  

  • 35. Chest wall resection for lung cancer: indications and techniques.
    Stoelben E; Ludwig C
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):450-6. PubMed ID: 19188079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staging and resection of lung cancer with minimal invasion of the adjacent lobe.
    Demir A; Gunluoglu MZ; Sansar D; Melek H; Dincer SI
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):855-8. PubMed ID: 17936002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity does not increase complications after anatomic resection for non-small cell lung cancer.
    Smith PW; Wang H; Gazoni LM; Shen KR; Daniel TM; Jones DR
    Ann Thorac Surg; 2007 Oct; 84(4):1098-105; discussion 1105-6. PubMed ID: 17888954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Issues in the management of chest malignancies.
    Faber LP
    Clin Chest Med; 1992 Mar; 13(1):113-35. PubMed ID: 1316255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment?
    Chamogeorgakis T; Anagnostopoulos C; Kostopanagiotou G; Bhora F; Toumpoulis I; Georgiannakis E; Nabong A; Dosios T; Harrison L; Connery C
    Thorac Cardiovasc Surg; 2008 Apr; 56(3):148-53. PubMed ID: 18365973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
    Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
    Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.